Skip to main content

Month: May 2025

NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 11, 2025

EINDHOVEN, The Netherlands, May 02, 2025 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) will hold its annual meeting of shareholders on Wednesday, June 11, 2025 at 08.45 a.m. CET at the Sheraton Amsterdam Airport Hotel and Conference Center, Schiphol Boulevard 101, 1118 BG Amsterdam, The Netherlands. NXP has filed its definitive proxy statement and annual report with the U.S. Securities and Exchange Commission and this proxy statement and other related meeting materials are also available at nxp.com/agm. NXP intends to use the notice and access proxy distribution method and expects to distribute the notice of internet availability of proxy materials no later than May 21, 2025. Shareholders may request paper copies of the proxy materials by sending a request to: NXP Semiconductors N.V., High Tech Campus 60, 5656 AG, Eindhoven,...

Continue reading

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications

XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, 2025, the Company received a letter (the “Notification Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it was not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”), as the Company’s closing bid price for its Class A ordinary shares, par value US$0.001 per share was below $1.00 per share for the prior thirty (30) consecutive business days, which matter serves as a basis for delisting the Company’s securities from Nasdaq. Additionally, the Company’s securities...

Continue reading

Update on Market Making Arrangements

Reykjavík, May 02, 2025 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company” or the “Corporation”) Update on Market Making Arrangements TORONTO, ONTARIO – May 02, 2025 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mining company with a substantial land package of gold and strategic mineral assets in Southern Greenland, announces that it has signed an amendment to its existing market making agreement with Arion Bank hf., originally dated January 24, 2025. The amendment introduces a two-part structure for daily bid and ask quotes, requiring Arion Bank to submit quotes for a minimum of 50,000 Depository Receipts. Under the updated terms:For 45,000 Depository Receipts (“Part A”), the bid-ask spread is determined with reference to the tick size table as current at any given time, so that the spread will be as close...

Continue reading

Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025

BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2025, after the market closes on Thursday, May 8, 2025. Management has updated the time of its call and will host a conference call and audio webcast on Thursday, May 8, 2025, at 4:00 p.m. ET to discuss the Company’s financial results.Event: First Quarter 2025 Financial Results Conference CallDate: Thursday, May 8, 2025Time: 4:00 p.m. Eastern TimeLive Call: 1-844-826-3033 (U.S. & Canada Toll-Free)Conference ID 10197772Webcast: Register   For interested individuals unable to join the conference call, a webcast of the call will be...

Continue reading

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that, following the Company’s recent press release highlighting the Direct Registration System (DRS) as a secure method of share ownership, it has received a number of inquiries from shareholders seeking additional information on how to transfer their shares to a DRS account. In response, Tevogen will provide step-by-step guidance early next week to help interested shareholders register their shares directly with the Company’s transfer agent, Continental Stock Transfer & Trust. The Company also notes that several of its largest shareholders, both internal and external, have elected to hold their shares via DRS, underscoring their confidence in this method of direct ownership. Contacts Tevogen Bio...

Continue reading

GFG Closes Oversubscribed Financing

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES SASKATOON, Saskatchewan, May 02, 2025 (GLOBE NEWSWIRE) — GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) has closed its private placement financing (the “Offering”) for gross proceeds of C$3,000,000. In connection with the Offering, Alamos Gold Inc. (“Alamos”) (TSX: AGI; NYSE: AGI) purchased securities and will hold a 10.8% interest in the Company. Brian Skanderbeg, President and CEO of GFG commented, “This successful financing, along with the continued support from Alamos, is a testament to our long-term strategy, strong asset base, and promising growth prospects. With a strong cash position, we have the capability to sustain our aggressive exploration strategy, with a focus on advancing the Aljo Gold Project to resource stage and making...

Continue reading

Great Elm Group, Inc. Schedules Fiscal 2025 Third Quarter Conference Call and Webcast

PALM BEACH GARDENS, Fla., May 02, 2025 (GLOBE NEWSWIRE) — Great Elm Group, Inc. (“Great Elm”) (NASDAQ: GEG), today announced plans to release financial results for the fiscal quarter ended March 31, 2025, after the close of market trading on Wednesday, May 7, 2025.    Company to Host Conference Call & Webcast Great Elm will also host a conference call and webcast on Thursday, May 8, 2025, at 8:30 a.m. Eastern Time to discuss its fiscal 2025 third quarter financial results.    All interested parties are invited to participate in the conference call by dialing +1 (877) 407-0752; international callers should dial +1 (201) 389-0912. Participants should enter the Conference ID 13746971 if asked. A copy of the slide presentation that will be referenced during the conference call can be found here. The conference call will be webcast...

Continue reading

Pacific Health Care Organization, Inc. Reports its First Quarter 2025 Financial Results

Irvine, CA, May 02, 2025 (GLOBE NEWSWIRE) — Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q announcing its financial results for the quarter ended March 31, 2025. Results The Company reported total revenues of $1,818,814 for the quarter ended March 31, 2025, compared to $1,397,831 for the quarter ended March 31, 2024. The Company reported income from operations of $314,419 for the quarter ended March 31, 2025, compared to income from operations of $175,193 for the quarter ended March 31, 2024. The Company realized net income of $292,663 or $0.02 per weighted average share outstanding, basic and diluted, for the quarter ended March 31, 2025, compared to net income of $197,403 or $0.02 per weighted average share...

Continue reading

IBA launches myQA Blue Phantom³ for radiation therapy quality assurance

Fastest automatic levelling offering on the market Seamless integration with all linear accelerators Louvain-la-Neuve, Belgium, 2 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a leading provider of dosimetry and quality assurance (QA) solutions, announces the launch of myQA Blue Phantom³ at the European Society for Radiotherapy and Oncology (ESTRO) 2025 annual congress in Vienna, Austria. This innovative solution is set to transform the field of radiotherapy by enhancing precision and efficiency in treatment delivery and quality assurance. myQA Blue Phantom³ is designed for fast and high-precision quality assurance and commissioning. The system allows automatic levelling in under 30 seconds, the fastest offering in the market, ensuring valuable timesaving during the highly...

Continue reading

Village Farms International Reschedules Q1 2025 Conference Call

VANCOUVER, British Columbia, May 02, 2025 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced it has rescheduled its previously announced conference call to discuss its first quarter 2025 financial results to Tuesday, May 13, 2025, at 8:30 a.m. ET. Participants can access the conference call via a webcast at Village Farms First Quarter 2025 Conference Call Webcast or on the Company website at Village Farms – Events. Participants wanting to access the conference call by telephone must register in advance at Village Farms First Quarter 2025 Conference Call Registration to receive telephone dial-in information. The live question and answer session will be limited to analysts; however, others are invited to submit questions ahead of the conference call via email...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.